-transparent.png){kind=logo}
Numerous mechanisms have been proposed to account for deficient bilirubin excretion and the pathogenesis of estrogen and steroid (danazol) induced intrahepatic cholestasis. Our hypothesis is based on the fact that danazol is administered in the treatment of pulmonary emphysema because it stimulates synthesis of alpha-1 antitrypsin and that other estrogen glucuro-conjugated metabolites are P-glycoprotein substrates. We believe that genetic alterations of alpha-1 antitrypsin and P-glycoprotein, either alone or in association with known pathogenetic mechanisms, may explain the onset of danazol induced cholestasis and justify the difference in its varying duration and intensity.
M Malaguarnera, and
N Santangelo, and
M Motta, and
G Pistone
April 1989,
The American journal of gastroenterology,
M Malaguarnera, and
N Santangelo, and
M Motta, and
G Pistone
March 1993,
Postgraduate medical journal,
M Malaguarnera, and
N Santangelo, and
M Motta, and
G Pistone
January 1996,
Ultrastructural pathology,
M Malaguarnera, and
N Santangelo, and
M Motta, and
G Pistone
January 1979,
Anales otorrinolaringologicos ibero-americanos,
M Malaguarnera, and
N Santangelo, and
M Motta, and
G Pistone
May 1953,
Minerva dermatologica,
M Malaguarnera, and
N Santangelo, and
M Motta, and
G Pistone
October 1993,
Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna,
M Malaguarnera, and
N Santangelo, and
M Motta, and
G Pistone
January 1974,
Minerva nefrologica,
M Malaguarnera, and
N Santangelo, and
M Motta, and
G Pistone
January 1961,
Archivio italiano di otologia, rinologia e laringologia,
M Malaguarnera, and
N Santangelo, and
M Motta, and
G Pistone
March 1987,
British journal of haematology,
M Malaguarnera, and
N Santangelo, and
M Motta, and
G Pistone
July 1997,
The Tohoku journal of experimental medicine,
